NHS preparing to offer ‘game-changing’ cancer treatment – The Guardian
The Guardian |
NHS preparing to offer ‘game-changing’ cancer treatment
The Guardian The treatments, which are hugely expensive, work by genetically engineering the patient’s immune system’s killer T–cells to recognise and destroy cancer cells. In trials, they have had extraordinary success, putting into remission patients who had only … NHS set to offer cancer patients a ‘game changer’ treatment that could save THOUSANDS of livesDaily Mail Pioneering cancer therapy to be made available to NHS patientsThe Irish News |
AOL UK |
Pioneering cancer therapy to be made available to NHS patients
AOL UK A charity has welcomed news that a pioneering therapy that uses a patient’s own genetically modified cells to fight cancer will be made available to NHS patients. Chimeric antigen receptor T–cell therapy (CAR-T) will be “one of the most innovative … New CAR-T therapy could provide safer, more effective cancer …Brinkwire (press release) |
UConn Today |
UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD
UConn Today A ground-breaking clinical trial focusing on Glycogen Storage Disease (GSD) Type Ia will be hosted by the GSD Program at Connecticut Children’s Medical Center and UConn Health, under the direction of pediatric endocrinologist and scientist Dr. David … |
FierceBiotech |
Jennifer Doudna’s new CRISPR company will tackle disease detection
FierceBiotech “In CRISPR, you type a guide RNA into a protein to tell it what to find.” It then looks for whatever sequence is complementary to the guide RNA. Instead of using the technology to target and then delete or replace a faulty sequence, Mammoth is using it … |